Loading…

Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig

One of the challenges in clinical translation of cell-replacement therapies is the definition of optimal cell generation and storage/recovery protocols which would permit a rapid preparation of cell-treatment products for patient administration. Besides, the availability of injection devices that ar...

Full description

Saved in:
Bibliographic Details
Published in:Cell transplantation 2023-01, Vol.32, p.9636897221107009-9636897221107009
Main Authors: Kobayashi, Yoshiomi, Shigyo, Michiko, Platoshyn, Oleksandr, Marsala, Silvia, Kato, Tomohisa, Takamura, Naoki, Yoshida, Kenji, Kishino, Akiyoshi, Bravo-Hernandez, Mariana, Juhas, Stefan, Juhasova, Jana, Studenovska, Hana, Proks, Vladimir, Driscoll, Shawn P., Glenn, Thomas D., Pfaff, Samuel L., Ciacci, Joseph D., Marsala, Martin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c419t-c451527221ad2d2938a8a2f701b8e21a018eec3e43f74131dd78eac97a4947543
container_end_page 9636897221107009
container_issue
container_start_page 9636897221107009
container_title Cell transplantation
container_volume 32
creator Kobayashi, Yoshiomi
Shigyo, Michiko
Platoshyn, Oleksandr
Marsala, Silvia
Kato, Tomohisa
Takamura, Naoki
Yoshida, Kenji
Kishino, Akiyoshi
Bravo-Hernandez, Mariana
Juhas, Stefan
Juhasova, Jana
Studenovska, Hana
Proks, Vladimir
Driscoll, Shawn P.
Glenn, Thomas D.
Pfaff, Samuel L.
Ciacci, Joseph D.
Marsala, Martin
description One of the challenges in clinical translation of cell-replacement therapies is the definition of optimal cell generation and storage/recovery protocols which would permit a rapid preparation of cell-treatment products for patient administration. Besides, the availability of injection devices that are simple to use is critical for potential future dissemination of any spinally targeted cell-replacement therapy into general medical practice. Here, we compared the engraftment properties of established human-induced pluripotent stem cells (hiPSCs)-derived neural precursor cell (NPCs) line once cells were harvested fresh from the cell culture or previously frozen and then grafted into striata or spinal cord of the immunodeficient rat. A newly developed human spinal injection device equipped with a spinal cord pulsation-cancelation magnetic needle was also tested for its safety in an adult immunosuppressed pig. Previously frozen NPCs showed similar post-grafting survival and differentiation profile as was seen for freshly harvested cells. Testing of human injection device showed acceptable safety with no detectable surgical procedure or spinal NPCs injection-related side effects.
doi_str_mv 10.1177/09636897221107009
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10134149</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_09636897221107009</sage_id><sourcerecordid>3095716692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-c451527221ad2d2938a8a2f701b8e21a018eec3e43f74131dd78eac97a4947543</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EokPhAdggS2zYpNhxHNtsUDUqbaUKRh3o1rqT3KSuMvHUdiraJ-hj49GU8ic2tuX73XN9fAh5zdkB50q9Z6YWtTaqLDlnijHzhMy4lLIQ2pRPyWxbL7bAHnkR4xVjTIlSPid7QjGtjVYzcn_0fQNjC6sB6RLzwRUXLkyxOMdN8H2A9RpbejKtYaRusZwXn3EKfoSBLgI2U4g-xA_0dKQX7sbThY-pOA7QJTf2dAkdpls6v4QATcLg7iA5n3VGeg4p0jyXHrbTkOjC9S_Jsw6GiK8e9n3y7dPR1_lJcfbl-HR-eFY0FTcpr5LLcusY2rItjdCgoewU4yuN-ZJxjdgIrESnKi542yqN0BgFlamUrMQ--bjT3UyrbK3BMQUY7Ca4NYRb68HZPyuju7S9v7GccVHxymSFdw8KwV9PGJNdu9jgMMCIfoq21ExKbmrJMvr2L_TKTyH_XrSCGal4XZsyU3xHNcHHGLB7fA1ndhu0_Sfo3PPmdxuPHT-TzcDBDojQ46-x_1f8AUk5sUo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3095716692</pqid></control><display><type>article</type><title>Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig</title><source>SAGE Open Access Journals</source><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Kobayashi, Yoshiomi ; Shigyo, Michiko ; Platoshyn, Oleksandr ; Marsala, Silvia ; Kato, Tomohisa ; Takamura, Naoki ; Yoshida, Kenji ; Kishino, Akiyoshi ; Bravo-Hernandez, Mariana ; Juhas, Stefan ; Juhasova, Jana ; Studenovska, Hana ; Proks, Vladimir ; Driscoll, Shawn P. ; Glenn, Thomas D. ; Pfaff, Samuel L. ; Ciacci, Joseph D. ; Marsala, Martin</creator><creatorcontrib>Kobayashi, Yoshiomi ; Shigyo, Michiko ; Platoshyn, Oleksandr ; Marsala, Silvia ; Kato, Tomohisa ; Takamura, Naoki ; Yoshida, Kenji ; Kishino, Akiyoshi ; Bravo-Hernandez, Mariana ; Juhas, Stefan ; Juhasova, Jana ; Studenovska, Hana ; Proks, Vladimir ; Driscoll, Shawn P. ; Glenn, Thomas D. ; Pfaff, Samuel L. ; Ciacci, Joseph D. ; Marsala, Martin</creatorcontrib><description>One of the challenges in clinical translation of cell-replacement therapies is the definition of optimal cell generation and storage/recovery protocols which would permit a rapid preparation of cell-treatment products for patient administration. Besides, the availability of injection devices that are simple to use is critical for potential future dissemination of any spinally targeted cell-replacement therapy into general medical practice. Here, we compared the engraftment properties of established human-induced pluripotent stem cells (hiPSCs)-derived neural precursor cell (NPCs) line once cells were harvested fresh from the cell culture or previously frozen and then grafted into striata or spinal cord of the immunodeficient rat. A newly developed human spinal injection device equipped with a spinal cord pulsation-cancelation magnetic needle was also tested for its safety in an adult immunosuppressed pig. Previously frozen NPCs showed similar post-grafting survival and differentiation profile as was seen for freshly harvested cells. Testing of human injection device showed acceptable safety with no detectable surgical procedure or spinal NPCs injection-related side effects.</description><identifier>ISSN: 0963-6897</identifier><identifier>EISSN: 1555-3892</identifier><identifier>DOI: 10.1177/09636897221107009</identifier><identifier>PMID: 37088987</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Adult ; Animals ; Brain ; Cell culture ; Cell differentiation ; Cell Differentiation - physiology ; Cell survival ; Cellular Reprogramming - genetics ; Cellular Reprogramming - physiology ; Genetic Vectors - genetics ; Graft Survival - physiology ; Humans ; Immunodeficiency ; Induced Pluripotent Stem Cells - physiology ; Induced Pluripotent Stem Cells - transplantation ; Injection ; Injections, Spinal - adverse effects ; Injections, Spinal - instrumentation ; Injections, Spinal - methods ; Neural stem cells ; Neural Stem Cells - physiology ; Neural Stem Cells - transplantation ; Original ; Pluripotency ; Rats ; Sendai virus ; Specimen Handling - methods ; Spinal Cord ; Stem Cell Transplantation - adverse effects ; Stem Cell Transplantation - instrumentation ; Stem Cell Transplantation - methods ; Swine ; Tissue and Organ Harvesting - methods ; Treatment Outcome</subject><ispartof>Cell transplantation, 2023-01, Vol.32, p.9636897221107009-9636897221107009</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023 2023 SAGE Publications Inc, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c419t-c451527221ad2d2938a8a2f701b8e21a018eec3e43f74131dd78eac97a4947543</cites><orcidid>0000-0001-5048-6422</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134149/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3095716692?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,21994,25783,27886,27957,27958,37047,37048,44625,44980,45368,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37088987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kobayashi, Yoshiomi</creatorcontrib><creatorcontrib>Shigyo, Michiko</creatorcontrib><creatorcontrib>Platoshyn, Oleksandr</creatorcontrib><creatorcontrib>Marsala, Silvia</creatorcontrib><creatorcontrib>Kato, Tomohisa</creatorcontrib><creatorcontrib>Takamura, Naoki</creatorcontrib><creatorcontrib>Yoshida, Kenji</creatorcontrib><creatorcontrib>Kishino, Akiyoshi</creatorcontrib><creatorcontrib>Bravo-Hernandez, Mariana</creatorcontrib><creatorcontrib>Juhas, Stefan</creatorcontrib><creatorcontrib>Juhasova, Jana</creatorcontrib><creatorcontrib>Studenovska, Hana</creatorcontrib><creatorcontrib>Proks, Vladimir</creatorcontrib><creatorcontrib>Driscoll, Shawn P.</creatorcontrib><creatorcontrib>Glenn, Thomas D.</creatorcontrib><creatorcontrib>Pfaff, Samuel L.</creatorcontrib><creatorcontrib>Ciacci, Joseph D.</creatorcontrib><creatorcontrib>Marsala, Martin</creatorcontrib><title>Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig</title><title>Cell transplantation</title><addtitle>Cell Transplant</addtitle><description>One of the challenges in clinical translation of cell-replacement therapies is the definition of optimal cell generation and storage/recovery protocols which would permit a rapid preparation of cell-treatment products for patient administration. Besides, the availability of injection devices that are simple to use is critical for potential future dissemination of any spinally targeted cell-replacement therapy into general medical practice. Here, we compared the engraftment properties of established human-induced pluripotent stem cells (hiPSCs)-derived neural precursor cell (NPCs) line once cells were harvested fresh from the cell culture or previously frozen and then grafted into striata or spinal cord of the immunodeficient rat. A newly developed human spinal injection device equipped with a spinal cord pulsation-cancelation magnetic needle was also tested for its safety in an adult immunosuppressed pig. Previously frozen NPCs showed similar post-grafting survival and differentiation profile as was seen for freshly harvested cells. Testing of human injection device showed acceptable safety with no detectable surgical procedure or spinal NPCs injection-related side effects.</description><subject>Adult</subject><subject>Animals</subject><subject>Brain</subject><subject>Cell culture</subject><subject>Cell differentiation</subject><subject>Cell Differentiation - physiology</subject><subject>Cell survival</subject><subject>Cellular Reprogramming - genetics</subject><subject>Cellular Reprogramming - physiology</subject><subject>Genetic Vectors - genetics</subject><subject>Graft Survival - physiology</subject><subject>Humans</subject><subject>Immunodeficiency</subject><subject>Induced Pluripotent Stem Cells - physiology</subject><subject>Induced Pluripotent Stem Cells - transplantation</subject><subject>Injection</subject><subject>Injections, Spinal - adverse effects</subject><subject>Injections, Spinal - instrumentation</subject><subject>Injections, Spinal - methods</subject><subject>Neural stem cells</subject><subject>Neural Stem Cells - physiology</subject><subject>Neural Stem Cells - transplantation</subject><subject>Original</subject><subject>Pluripotency</subject><subject>Rats</subject><subject>Sendai virus</subject><subject>Specimen Handling - methods</subject><subject>Spinal Cord</subject><subject>Stem Cell Transplantation - adverse effects</subject><subject>Stem Cell Transplantation - instrumentation</subject><subject>Stem Cell Transplantation - methods</subject><subject>Swine</subject><subject>Tissue and Organ Harvesting - methods</subject><subject>Treatment Outcome</subject><issn>0963-6897</issn><issn>1555-3892</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kc1u1DAUhS0EokPhAdggS2zYpNhxHNtsUDUqbaUKRh3o1rqT3KSuMvHUdiraJ-hj49GU8ic2tuX73XN9fAh5zdkB50q9Z6YWtTaqLDlnijHzhMy4lLIQ2pRPyWxbL7bAHnkR4xVjTIlSPid7QjGtjVYzcn_0fQNjC6sB6RLzwRUXLkyxOMdN8H2A9RpbejKtYaRusZwXn3EKfoSBLgI2U4g-xA_0dKQX7sbThY-pOA7QJTf2dAkdpls6v4QATcLg7iA5n3VGeg4p0jyXHrbTkOjC9S_Jsw6GiK8e9n3y7dPR1_lJcfbl-HR-eFY0FTcpr5LLcusY2rItjdCgoewU4yuN-ZJxjdgIrESnKi542yqN0BgFlamUrMQ--bjT3UyrbK3BMQUY7Ca4NYRb68HZPyuju7S9v7GccVHxymSFdw8KwV9PGJNdu9jgMMCIfoq21ExKbmrJMvr2L_TKTyH_XrSCGal4XZsyU3xHNcHHGLB7fA1ndhu0_Sfo3PPmdxuPHT-TzcDBDojQ46-x_1f8AUk5sUo</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Kobayashi, Yoshiomi</creator><creator>Shigyo, Michiko</creator><creator>Platoshyn, Oleksandr</creator><creator>Marsala, Silvia</creator><creator>Kato, Tomohisa</creator><creator>Takamura, Naoki</creator><creator>Yoshida, Kenji</creator><creator>Kishino, Akiyoshi</creator><creator>Bravo-Hernandez, Mariana</creator><creator>Juhas, Stefan</creator><creator>Juhasova, Jana</creator><creator>Studenovska, Hana</creator><creator>Proks, Vladimir</creator><creator>Driscoll, Shawn P.</creator><creator>Glenn, Thomas D.</creator><creator>Pfaff, Samuel L.</creator><creator>Ciacci, Joseph D.</creator><creator>Marsala, Martin</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>AFRWT</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5048-6422</orcidid></search><sort><creationdate>20230101</creationdate><title>Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig</title><author>Kobayashi, Yoshiomi ; Shigyo, Michiko ; Platoshyn, Oleksandr ; Marsala, Silvia ; Kato, Tomohisa ; Takamura, Naoki ; Yoshida, Kenji ; Kishino, Akiyoshi ; Bravo-Hernandez, Mariana ; Juhas, Stefan ; Juhasova, Jana ; Studenovska, Hana ; Proks, Vladimir ; Driscoll, Shawn P. ; Glenn, Thomas D. ; Pfaff, Samuel L. ; Ciacci, Joseph D. ; Marsala, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-c451527221ad2d2938a8a2f701b8e21a018eec3e43f74131dd78eac97a4947543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Animals</topic><topic>Brain</topic><topic>Cell culture</topic><topic>Cell differentiation</topic><topic>Cell Differentiation - physiology</topic><topic>Cell survival</topic><topic>Cellular Reprogramming - genetics</topic><topic>Cellular Reprogramming - physiology</topic><topic>Genetic Vectors - genetics</topic><topic>Graft Survival - physiology</topic><topic>Humans</topic><topic>Immunodeficiency</topic><topic>Induced Pluripotent Stem Cells - physiology</topic><topic>Induced Pluripotent Stem Cells - transplantation</topic><topic>Injection</topic><topic>Injections, Spinal - adverse effects</topic><topic>Injections, Spinal - instrumentation</topic><topic>Injections, Spinal - methods</topic><topic>Neural stem cells</topic><topic>Neural Stem Cells - physiology</topic><topic>Neural Stem Cells - transplantation</topic><topic>Original</topic><topic>Pluripotency</topic><topic>Rats</topic><topic>Sendai virus</topic><topic>Specimen Handling - methods</topic><topic>Spinal Cord</topic><topic>Stem Cell Transplantation - adverse effects</topic><topic>Stem Cell Transplantation - instrumentation</topic><topic>Stem Cell Transplantation - methods</topic><topic>Swine</topic><topic>Tissue and Organ Harvesting - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kobayashi, Yoshiomi</creatorcontrib><creatorcontrib>Shigyo, Michiko</creatorcontrib><creatorcontrib>Platoshyn, Oleksandr</creatorcontrib><creatorcontrib>Marsala, Silvia</creatorcontrib><creatorcontrib>Kato, Tomohisa</creatorcontrib><creatorcontrib>Takamura, Naoki</creatorcontrib><creatorcontrib>Yoshida, Kenji</creatorcontrib><creatorcontrib>Kishino, Akiyoshi</creatorcontrib><creatorcontrib>Bravo-Hernandez, Mariana</creatorcontrib><creatorcontrib>Juhas, Stefan</creatorcontrib><creatorcontrib>Juhasova, Jana</creatorcontrib><creatorcontrib>Studenovska, Hana</creatorcontrib><creatorcontrib>Proks, Vladimir</creatorcontrib><creatorcontrib>Driscoll, Shawn P.</creatorcontrib><creatorcontrib>Glenn, Thomas D.</creatorcontrib><creatorcontrib>Pfaff, Samuel L.</creatorcontrib><creatorcontrib>Ciacci, Joseph D.</creatorcontrib><creatorcontrib>Marsala, Martin</creatorcontrib><collection>SAGE Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kobayashi, Yoshiomi</au><au>Shigyo, Michiko</au><au>Platoshyn, Oleksandr</au><au>Marsala, Silvia</au><au>Kato, Tomohisa</au><au>Takamura, Naoki</au><au>Yoshida, Kenji</au><au>Kishino, Akiyoshi</au><au>Bravo-Hernandez, Mariana</au><au>Juhas, Stefan</au><au>Juhasova, Jana</au><au>Studenovska, Hana</au><au>Proks, Vladimir</au><au>Driscoll, Shawn P.</au><au>Glenn, Thomas D.</au><au>Pfaff, Samuel L.</au><au>Ciacci, Joseph D.</au><au>Marsala, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig</atitle><jtitle>Cell transplantation</jtitle><addtitle>Cell Transplant</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>32</volume><spage>9636897221107009</spage><epage>9636897221107009</epage><pages>9636897221107009-9636897221107009</pages><issn>0963-6897</issn><eissn>1555-3892</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><notes>Yoshiomi Kobayashi is also affilated to The National Medical Center for Spine and Spinal Cord disease, Murayama Medical Center, Gakuen, Musashimurayama city, Tokyo, Japan</notes><notes>Co-first author</notes><abstract>One of the challenges in clinical translation of cell-replacement therapies is the definition of optimal cell generation and storage/recovery protocols which would permit a rapid preparation of cell-treatment products for patient administration. Besides, the availability of injection devices that are simple to use is critical for potential future dissemination of any spinally targeted cell-replacement therapy into general medical practice. Here, we compared the engraftment properties of established human-induced pluripotent stem cells (hiPSCs)-derived neural precursor cell (NPCs) line once cells were harvested fresh from the cell culture or previously frozen and then grafted into striata or spinal cord of the immunodeficient rat. A newly developed human spinal injection device equipped with a spinal cord pulsation-cancelation magnetic needle was also tested for its safety in an adult immunosuppressed pig. Previously frozen NPCs showed similar post-grafting survival and differentiation profile as was seen for freshly harvested cells. Testing of human injection device showed acceptable safety with no detectable surgical procedure or spinal NPCs injection-related side effects.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>37088987</pmid><doi>10.1177/09636897221107009</doi><orcidid>https://orcid.org/0000-0001-5048-6422</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0963-6897
ispartof Cell transplantation, 2023-01, Vol.32, p.9636897221107009-9636897221107009
issn 0963-6897
1555-3892
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10134149
source SAGE Open Access Journals; ProQuest - Publicly Available Content Database; PubMed Central
subjects Adult
Animals
Brain
Cell culture
Cell differentiation
Cell Differentiation - physiology
Cell survival
Cellular Reprogramming - genetics
Cellular Reprogramming - physiology
Genetic Vectors - genetics
Graft Survival - physiology
Humans
Immunodeficiency
Induced Pluripotent Stem Cells - physiology
Induced Pluripotent Stem Cells - transplantation
Injection
Injections, Spinal - adverse effects
Injections, Spinal - instrumentation
Injections, Spinal - methods
Neural stem cells
Neural Stem Cells - physiology
Neural Stem Cells - transplantation
Original
Pluripotency
Rats
Sendai virus
Specimen Handling - methods
Spinal Cord
Stem Cell Transplantation - adverse effects
Stem Cell Transplantation - instrumentation
Stem Cell Transplantation - methods
Swine
Tissue and Organ Harvesting - methods
Treatment Outcome
title Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T08%3A54%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expandable%20Sendai-Virus-Reprogrammed%20Human%20iPSC-Neuronal%20Precursors:%20In%20Vivo%20Post-Grafting%20Safety%20Characterization%20in%20Rats%20and%20Adult%20Pig&rft.jtitle=Cell%20transplantation&rft.au=Kobayashi,%20Yoshiomi&rft.date=2023-01-01&rft.volume=32&rft.spage=9636897221107009&rft.epage=9636897221107009&rft.pages=9636897221107009-9636897221107009&rft.issn=0963-6897&rft.eissn=1555-3892&rft_id=info:doi/10.1177/09636897221107009&rft_dat=%3Cproquest_pubme%3E3095716692%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-c451527221ad2d2938a8a2f701b8e21a018eec3e43f74131dd78eac97a4947543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3095716692&rft_id=info:pmid/37088987&rft_sage_id=10.1177_09636897221107009&rfr_iscdi=true